Trial · NCT00184717
Participant flow35
How many started, completed or left each group, period by period.
1 to 20 of 35
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Main Period (GHLIQUID-1516) | STARTED | 0.033 mg / NN-220 | 39 | |
| Main Period (GHLIQUID-1516) | STARTED | 0.067 mg / NN-220 | 38 | |
| Main Period (GHLIQUID-1516) | STARTED | No Treatment | 21 | |
| Main Period (GHLIQUID-1516) | STARTED | No Treatment --> 0.033 mg | 0 | |
| Main Period (GHLIQUID-1516) | STARTED | No Treatment --> 0.067 mg | 0 | |
| Main Period (GHLIQUID-1516) | Exposed to Trial Drug | 0.033 mg / NN-220 | 38 | |
| Main Period (GHLIQUID-1516) | Exposed to Trial Drug | 0.067 mg / NN-220 | 38 | |
| Main Period (GHLIQUID-1516) | Exposed to Trial Drug | No Treatment | 21 | |
| Main Period (GHLIQUID-1516) | Exposed to Trial Drug | No Treatment --> 0.033 mg | 0 | |
| Main Period (GHLIQUID-1516) | Exposed to Trial Drug | No Treatment --> 0.067 mg | 0 | |
| Main Period (GHLIQUID-1516) | COMPLETED | 0.033 mg / NN-220 | 36 | |
| Main Period (GHLIQUID-1516) | COMPLETED | 0.067 mg / NN-220 | 36 | |
| Main Period (GHLIQUID-1516) | COMPLETED | No Treatment | 20 | |
| Main Period (GHLIQUID-1516) | COMPLETED | No Treatment --> 0.033 mg | 0 | |
| Main Period (GHLIQUID-1516) | COMPLETED | No Treatment --> 0.067 mg | 0 | |
| Main Period (GHLIQUID-1516) | NOT COMPLETED | 0.033 mg / NN-220 | 3 | |
| Main Period (GHLIQUID-1516) | NOT COMPLETED | 0.067 mg / NN-220 | 2 | |
| Main Period (GHLIQUID-1516) | NOT COMPLETED | No Treatment | 1 | |
| Main Period (GHLIQUID-1516) | NOT COMPLETED | No Treatment --> 0.033 mg | 0 | |
| Main Period (GHLIQUID-1516) | NOT COMPLETED | No Treatment --> 0.067 mg | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00184717/flow